跳至主要内容
临床试验/NL-OMON26767
NL-OMON26767已完成不适用

Randomized study on hemoglobin response in iron-deficient anemic patients with solid maglignancies receiving epoetin alfa (rHuEPO) in combination with either oral or parental iron supplementation during treatment with non-platinum containing chemotherapy.

VU medisch centrum0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
34